NervGen Pharma Corp. (NasdaqCM: NGEN)
Health Care · Pharmaceuticals · CA
$1.73
-2.81% today · -48.7% 1Y
NervGen Pharma Corp. (NasdaqCM: NGEN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $186.01M and employs 8 people.
Over the last twelve months the share price has lost 48.7%, trading between 1.58 and 6.30.
Tweenvest scores NervGen Pharma Corp. across four factors: quality 32/100, value 30/100. Its strongest factor is quality.
NGEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $186.01M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.91
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- $6.30
- 52-week low
- $1.58
- Avg volume (3M)
- —
- Shares outstanding
- 107.52M
- Employees
- 8
- Next earnings
- —
About NervGen Pharma Corp.
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
- ISIN
- CA64082X2032
- Founded
- 2017
- Listed since
- Feb 8, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Korea United Pharm Inc.KOSE: A033270 | $189.84M | ₩17,860.00 | +1.88% |
| BioVersys AGSWX: BIOV | $187.08M | CHF25.40 | -4.15% |
| NGL Fine-Chem LimitedBSE: 524774 | $186.76M | Rs2,925.65 | +0.01% |
| MINAPHARM PharmaceuticalsCASE: MIPH | $186.58M | EGP829.40 | +2.08% |
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $185.57M | NT$59.70 | +1.02% |
| Dawnrays Pharmaceutical (Holdings) LimitedSEHK: 2348 | $184.28M | HK$0.96 | -0.52% |
| Formosa Laboratories, Inc.TWSE: 4746 | $184.10M | NT$48.95 | +1.77% |
| Alar Pharmaceuticals Inc.TPEX: 6785 | $184.05M | NT$88.10 | -6.97% |
Figures last refreshed Oct 11, 2026.